Join
Live feed
·
INSIDERFilingvia Quantisnow
Vickers Vantage Corp. I logo

SEC Form 4: Sorrento Therapeutics, Inc. disposed of 73,740,795 shares, decreasing direct ownership by 54% to 61,985,795 units

ByQuantisnow·Wall Street's wire, on your screen.
VCKA· Vickers Vantage Corp. I
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCKA (Vickers Vantage Corp. I) and more on Quantisnow.